Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion

This publication has 59 references indexed in Scilit:

• Transfusion‐associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?
  Transfusion, 1999
• New variant Creutzfeldt-Jakob disease (nvCJD): The risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components
  Transfusion Medicine Reviews, 1999
• The Use and Quality Control of Leukocyte‐Depleted Cell Concentrates
  Vox Sanguinis, 1998
• Hypotensive Reactions Associated with Platelet Transfusions and Angiotensin‐Converting Enzyme Inhibitors
  Vox Sanguinis, 1998
• Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet?
  Transfusion, 1997
• The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview
  Transfusion, 1996
• Practical guidelines for process validation and process control of white cell‐reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)
  Transfusion, 1996
• The role of leukodepletion in the control of transfusion-transmitted disease
  Transfusion Medicine Reviews, 1995
• The Role of the Plasma from Platelet Concentrates in Transfusion Reactions
  New England Journal of Medicine, 1994
• Prevalence of Platelet Transfusion Reactions Before and After Implementation of Leukocyte-Depleted Platelet Concentrates by Filtration
  Vox Sanguinis, 1993